
Taofiq A Solola
Examiner (ID: 15817, Phone: (571)272-0709 , Office: P/1625 )
| Most Active Art Unit | 1625 |
| Art Unit(s) | 1613, 1622, 1626, 1625 |
| Total Applications | 3197 |
| Issued Applications | 2337 |
| Pending Applications | 273 |
| Abandoned Applications | 640 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 14273423
[patent_doc_number] => 20190133996
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-09
[patent_title] => PHENOL COMPOUND AND COMBINATION OF SAME WITH A BENZODIAZEPINE FUSED TO 1,4-DIHYDROPYRIDINE FOR TREATING DISEASES OF THE CENTRAL NERVOUS AND VASCULAR SYSTEMS
[patent_app_type] => utility
[patent_app_number] => 16/098683
[patent_app_country] => US
[patent_app_date] => 2017-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10227
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16098683
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/098683 | Phenol compound and combination of same with a benzodiazepine fused to 1,4-dihydropyridine for treating diseases of the central nervous and vascular systems | May 2, 2017 | Issued |
Array
(
[id] => 12030785
[patent_doc_number] => 20170320885
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-11-09
[patent_title] => 'PROCESS FOR THE PREPARATION OF INTERMEDIATES USEFUL IN THE PREPARATION OF HEPATITIS C VIRUS (HCV) INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 15/583722
[patent_app_country] => US
[patent_app_date] => 2017-05-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4183
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15583722
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/583722 | Process for the preparation of intermediates useful in the preparation of Hepatitis C virus (HCV) inhibitors | Apr 30, 2017 | Issued |
Array
(
[id] => 11834550
[patent_doc_number] => 20170216269
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-03
[patent_title] => 'METHODS OF TREATING DEVELOPMENTAL DISORDERS USING PIPRADROL'
[patent_app_type] => utility
[patent_app_number] => 15/493374
[patent_app_country] => US
[patent_app_date] => 2017-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6034
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15493374
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/493374 | Methods of treating developmental disorders using pipradrol | Apr 20, 2017 | Issued |
Array
(
[id] => 14276941
[patent_doc_number] => 20190135755
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-09
[patent_title] => CRYSTAL POLYMORPHISM OF KCNQ2-5 CHANNEL ACTIVATOR
[patent_app_type] => utility
[patent_app_number] => 16/095370
[patent_app_country] => US
[patent_app_date] => 2017-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9355
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16095370
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/095370 | CRYSTAL POLYMORPHISM OF KCNQ2-5 CHANNEL ACTIVATOR | Apr 20, 2017 | Abandoned |
Array
(
[id] => 14213831
[patent_doc_number] => 20190119300
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-04-25
[patent_title] => SUBSTITUTED AND FUSED 6-MEMBERED PROTEASE ACTIVATED RECEPTOR 4 (PAR-4) ANTAGONISTS
[patent_app_type] => utility
[patent_app_number] => 16/094822
[patent_app_country] => US
[patent_app_date] => 2017-04-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17270
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16094822
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/094822 | SUBSTITUTED AND FUSED 6-MEMBERED PROTEASE ACTIVATED RECEPTOR 4 (PAR-4) ANTAGONISTS | Apr 16, 2017 | Abandoned |
Array
(
[id] => 11991654
[patent_doc_number] => 20170295809
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-10-19
[patent_title] => 'LARGE SCALE METHODS OF UNIFORMLY COATING PACKAGING SURFACES WITH A VOLATILE ANTIMICROBIAL TO PRESERVE FOOD FRESHNESS'
[patent_app_type] => utility
[patent_app_number] => 15/485500
[patent_app_country] => US
[patent_app_date] => 2017-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16021
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15485500
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/485500 | LARGE SCALE METHODS OF UNIFORMLY COATING PACKAGING SURFACES WITH A VOLATILE ANTIMICROBIAL TO PRESERVE FOOD FRESHNESS | Apr 11, 2017 | Abandoned |
Array
(
[id] => 13957747
[patent_doc_number] => 20190055217
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-02-21
[patent_title] => PIPERIDINYLALKYLAMIDE DERIVATIVES HAVING MULTIMODAL ACTIVITY AGAINST PAIN
[patent_app_type] => utility
[patent_app_number] => 16/090385
[patent_app_country] => US
[patent_app_date] => 2017-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21769
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16090385
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/090385 | PIPERIDINYLALKYLAMIDE DERIVATIVES HAVING MULTIMODAL ACTIVITY AGAINST PAIN | Apr 11, 2017 | Abandoned |
Array
(
[id] => 14652561
[patent_doc_number] => 20190233409
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-01
[patent_title] => SUBSTITUTED 2,3,4,5-TETRAHYDRO-1H-PYRIDO[4,3-B]INDOLES, METHODS FOR USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 15/485269
[patent_app_country] => US
[patent_app_date] => 2017-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17315
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -2
[patent_words_short_claim] => 83
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15485269
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/485269 | SUBSTITUTED 2,3,4,5-TETRAHYDRO-1H-PYRIDO[4,3-B]INDOLES, METHODS FOR USE THEREOF | Apr 11, 2017 | Abandoned |
Array
(
[id] => 14406615
[patent_doc_number] => 20190169151
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-06
[patent_title] => THERAPEUTIC AURONES
[patent_app_type] => utility
[patent_app_number] => 16/092916
[patent_app_country] => US
[patent_app_date] => 2017-04-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 45122
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16092916
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/092916 | Therapeutic aurones | Apr 10, 2017 | Issued |
Array
(
[id] => 16695430
[patent_doc_number] => 10945999
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-03-16
[patent_title] => Ring-fused thiazolino 2-pyridones, methods for preparation thereof and their use in the treatment and/or prevention of tuberculosis
[patent_app_type] => utility
[patent_app_number] => 16/091774
[patent_app_country] => US
[patent_app_date] => 2017-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 22
[patent_no_of_words] => 13164
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 105
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16091774
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/091774 | Ring-fused thiazolino 2-pyridones, methods for preparation thereof and their use in the treatment and/or prevention of tuberculosis | Apr 6, 2017 | Issued |
Array
(
[id] => 14338613
[patent_doc_number] => 20190151279
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-23
[patent_title] => BENZO[B]FURANS AS BROMODOMAIN INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 16/091577
[patent_app_country] => US
[patent_app_date] => 2017-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 57769
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16091577
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/091577 | Benzo[b]furans as bromodomain inhibitors | Apr 4, 2017 | Issued |
Array
(
[id] => 14185161
[patent_doc_number] => 20190112285
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-04-18
[patent_title] => Aminothiazole Derivatives Useful As Antiviral Agents
[patent_app_type] => utility
[patent_app_number] => 16/088852
[patent_app_country] => US
[patent_app_date] => 2017-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12009
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 1059
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16088852
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/088852 | Aminothiazole derivatives useful as antiviral agents | Apr 4, 2017 | Issued |
Array
(
[id] => 14883423
[patent_doc_number] => 10421737
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-09-24
[patent_title] => Process for the preparation of optically active Beraprost
[patent_app_type] => utility
[patent_app_number] => 16/091019
[patent_app_country] => US
[patent_app_date] => 2017-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 1
[patent_no_of_words] => 2862
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 138
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16091019
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/091019 | Process for the preparation of optically active Beraprost | Mar 29, 2017 | Issued |
Array
(
[id] => 14649303
[patent_doc_number] => 20190231780
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-01
[patent_title] => ORGANIC COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 16/088397
[patent_app_country] => US
[patent_app_date] => 2017-03-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15443
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16088397
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/088397 | Organic compounds | Mar 23, 2017 | Issued |
Array
(
[id] => 14005467
[patent_doc_number] => 10221169
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-03-05
[patent_title] => Substituted aminothiazoles for the treatment of tuberculosis
[patent_app_type] => utility
[patent_app_number] => 15/467432
[patent_app_country] => US
[patent_app_date] => 2017-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14627
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15467432
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/467432 | Substituted aminothiazoles for the treatment of tuberculosis | Mar 22, 2017 | Issued |
Array
(
[id] => 12086188
[patent_doc_number] => 09839906
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2017-12-12
[patent_title] => 'Catalyst and method for synthesizing cyclic carbonate by the same'
[patent_app_type] => utility
[patent_app_number] => 15/465611
[patent_app_country] => US
[patent_app_date] => 2017-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 4446
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15465611
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/465611 | Catalyst and method for synthesizing cyclic carbonate by the same | Mar 21, 2017 | Issued |
Array
(
[id] => 11714860
[patent_doc_number] => 20170183359
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-06-29
[patent_title] => 'COMPOUND HAVING AGONISTIC ACTIVITY ON SOMATOSTATIN RECEPTOR, AND USE THEREOF FOR MEDICAL PURPOSES'
[patent_app_type] => utility
[patent_app_number] => 15/460466
[patent_app_country] => US
[patent_app_date] => 2017-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 68948
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15460466
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/460466 | Compound having agonistic activity on somatostatin receptor, and use thereof for medical purposes | Mar 15, 2017 | Issued |
Array
(
[id] => 15977925
[patent_doc_number] => 10669270
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-06-02
[patent_title] => Amide-sulfamide derivatives, compositions, and uses related to CXCR4 inhibition
[patent_app_type] => utility
[patent_app_number] => 16/085099
[patent_app_country] => US
[patent_app_date] => 2017-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 12
[patent_no_of_words] => 21686
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16085099
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/085099 | Amide-sulfamide derivatives, compositions, and uses related to CXCR4 inhibition | Mar 13, 2017 | Issued |
Array
(
[id] => 11954664
[patent_doc_number] => 20170258815
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-09-14
[patent_title] => 'CORTICOSTEROID FORMULATIONS AND METHODS FOR THE TREATMENT OF JOINT PAIN IN PATIENTS WITH DIABETES'
[patent_app_type] => utility
[patent_app_number] => 15/458383
[patent_app_country] => US
[patent_app_date] => 2017-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 19938
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15458383
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/458383 | CORTICOSTEROID FORMULATIONS AND METHODS FOR THE TREATMENT OF JOINT PAIN IN PATIENTS WITH DIABETES | Mar 13, 2017 | Abandoned |
Array
(
[id] => 11704454
[patent_doc_number] => 20170172953
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-06-22
[patent_title] => 'SELF-ASSEMBLING DRUG DELIVERY VEHICLES WITH IONICALLY CROSS-LINKED DRUGS'
[patent_app_type] => utility
[patent_app_number] => 15/449119
[patent_app_country] => US
[patent_app_date] => 2017-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 7850
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15449119
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/449119 | SELF-ASSEMBLING DRUG DELIVERY VEHICLES WITH IONICALLY CROSS-LINKED DRUGS | Mar 2, 2017 | Abandoned |